Neuropeptide Y inhibits sympathetic neurotransmission in ipsilaterally innervated but not contralaterally reinnervated superior tarsal smooth muscle of the rat

Abstract

The superior tarsal smooth muscle (STM), which elevates the upper eyelid, normally is innervated by sympathetic neurons from the ipsilateral superior cervical ganglion that are not neuropeptide Y-immunoreactive (NPY-ir). Following neonatal ganglionectomy, this target is reinnervated by sympathetic nerves from the contralateral superior cervical ganglion that are strongly NPY-ir. We examined the effects of exogenously administered NPY on STM tone, response to norepinephrine, and sympathetic neurotrans-mission in ipsilaterally innervated and contralaterally reinnervated STMs. NPY (2–10 μg/kg iv) increased blood pressure but did not alter STM tone. Similarly, contractile responses to co-administered norepinephrine were not affected. These findings imply an absence of direct and indirect postjunctional actions of NPY on STM. Contractions elicited by stimulation of the cervical sympathetic nerve (1.5 Hz) were not affected by NPY on the contralaterally reinnervated side; however, ipsilateral contractions were decreased in a dose-dependent fashion, with an inhibition of about 40% at 10 μg/kg. We conclude that while the STM is unresponsive to exogenously administered NPY, this peptide exerts selective inhibitory effects on the ipsilateral NPY-ir-negative but not the contralateral NPY-ir-positive innervation. This suggests that the neonatally denervated STM is reinnervated by contralateral fibers that are functionally different from the normal ipsilateral innervation in being devoid of functional prejunctional NPY receptors.